• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚两个州有注射吸毒史的成年囚犯中非致命性过量用药。

Non-fatal overdose among adult prisoners with a history of injecting drug use in two Australian states.

机构信息

Centre for Health Research in Criminal Justice, Justice & Forensic Mental Health Network, Pagewood, NSW 2035, Australia; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia.

出版信息

Drug Alcohol Depend. 2013 Nov 1;133(1):45-51. doi: 10.1016/j.drugalcdep.2013.06.001. Epub 2013 Jul 15.

DOI:10.1016/j.drugalcdep.2013.06.001
PMID:23866987
Abstract

BACKGROUND

Recently released prisoners are at markedly increased risk of death and drug-related causes predominate. Non-fatal overdose (NFOD) is considerably more common than fatal overdose, but has received relatively little research attention and most studies of NFOD in this population have suffered from small samples of unknown representativeness. This study aimed to estimate the prevalence and correlates of lifetime NFOD among prisoners in NSW and Queensland.

METHODS

Cross-sectional surveys of adult prisoners in two Australian states: New South Wales (n=972) and Queensland (n=1316). Use of similar measures and methods in the two states made direct comparison of findings possible.

RESULTS

In both NSW and Queensland, 23% of participants reported a lifetime history of NFOD and prisoners with a history of injecting drug use were significantly more likely to report lifetime NFOD. The lifetime prevalence of NFOD among prisoners with a history of injecting drug use was significantly higher in NSW than in Queensland (44% vs. 35%; p<0.01). Independent correlates of lifetime NFOD were similar across the two states and included ever attempting suicide, ever injecting heroin, and ever injecting opioids.

CONCLUSIONS

The risk of NFOD among prisoners with a history of injecting drug use is high. An understanding of the risk factors for NFOD in this population can inform targeted, evidence-based interventions to reduce this risk.

摘要

背景

最近获释的囚犯死亡风险明显增加,且死亡原因主要与毒品有关。非致命性药物过量(NFOD)比致命性药物过量更为常见,但受到的研究关注相对较少,且该人群中对 NFOD 的大多数研究都存在样本量小且代表性未知的问题。本研究旨在估计澳大利亚新南威尔士州和昆士兰州囚犯中终生 NFOD 的患病率及其相关因素。

方法

对澳大利亚两个州的成年囚犯进行横断面调查:新南威尔士州(n=972)和昆士兰州(n=1316)。两个州使用类似的措施和方法,使得研究结果可以直接进行比较。

结果

在新南威尔士州和昆士兰州,均有 23%的参与者报告有终生 NFOD 史,有注射吸毒史的囚犯更有可能报告终生 NFOD。有注射吸毒史的囚犯中,终生 NFOD 的患病率在新南威尔士州显著高于昆士兰州(44% vs. 35%;p<0.01)。终生 NFOD 的独立相关因素在两个州相似,包括曾经试图自杀、曾经注射海洛因和曾经注射阿片类药物。

结论

有注射吸毒史的囚犯发生 NFOD 的风险很高。了解该人群中 NFOD 的风险因素可以为有针对性的、基于证据的干预措施提供信息,以降低这种风险。

相似文献

1
Non-fatal overdose among adult prisoners with a history of injecting drug use in two Australian states.澳大利亚两个州有注射吸毒史的成年囚犯中非致命性过量用药。
Drug Alcohol Depend. 2013 Nov 1;133(1):45-51. doi: 10.1016/j.drugalcdep.2013.06.001. Epub 2013 Jul 15.
2
Opiate substitution treatment to reduce in-prison drug injection: a natural experiment.阿片类药物替代治疗以减少狱中药物注射:一项自然实验。
Int J Drug Policy. 2013 Sep;24(5):460-3. doi: 10.1016/j.drugpo.2013.01.004. Epub 2013 Mar 1.
3
Comparing the predictive capability of self-report and medically-verified non-fatal overdose in adults released from prison: A prospective data linkage study.比较出狱成年人自我报告和医学验证的非致命过量用药的预测能力:一项前瞻性数据链接研究。
Drug Alcohol Depend. 2020 Jan 1;206:107742. doi: 10.1016/j.drugalcdep.2019.107742. Epub 2019 Nov 14.
4
High-risk drug-use practices among a large sample of Australian prisoners.高危药物使用行为在澳大利亚大量囚犯中普遍存在。
Drug Alcohol Depend. 2012 Nov 1;126(1-2):156-60. doi: 10.1016/j.drugalcdep.2012.05.008. Epub 2012 May 30.
5
Non-fatal drug overdose after release from prison: A prospective data linkage study.出狱后非致命性药物过量:一项前瞻性数据链接研究。
Drug Alcohol Depend. 2020 Jan 1;206:107707. doi: 10.1016/j.drugalcdep.2019.107707. Epub 2019 Nov 9.
6
Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.澳大利亚昆士兰州注射毒品者出狱后非致命药物过量的发生率及预测因素
Drug Alcohol Depend. 2015 Aug 1;153:43-9. doi: 10.1016/j.drugalcdep.2015.06.011. Epub 2015 Jun 16.
7
Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users.最近被监禁的非法药物使用者队列中非致命性过量的发生率和危险因素。
Addict Behav. 2012 Jun;37(6):691-6. doi: 10.1016/j.addbeh.2012.01.019. Epub 2012 Feb 7.
8
Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.澳大利亚注射吸毒者便利样本中与非病毒注射相关的伤害和疾病的患病率及其相关因素。
Drug Alcohol Depend. 2009 Feb 1;100(1-2):9-16. doi: 10.1016/j.drugalcdep.2008.08.016. Epub 2008 Nov 14.
9
Past 12-month nonfatal overdose among people who inject drugs in Ukraine: City-level estimates and risk factors from a cross-sectional study.乌克兰注射吸毒者过去 12 个月内非致命性过量用药情况:一项横断面研究的城市层面估计数和风险因素。
Drug Alcohol Depend. 2021 Mar 1;220:108513. doi: 10.1016/j.drugalcdep.2021.108513. Epub 2021 Jan 9.
10
Effects of a sustained heroin shortage in three Australian States.澳大利亚三个州海洛因持续短缺的影响。
Addiction. 2005 Jul;100(7):908-20. doi: 10.1111/j.1360-0443.2005.01094.x.

引用本文的文献

1
Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses.非致命性和致命性阿片类药物过量血液样本中的精神活性物质浓度。
Br J Clin Pharmacol. 2022 Oct;88(10):4494-4504. doi: 10.1111/bcp.15365. Epub 2022 May 13.
2
A scoping review of factors that influence opioid overdose prevention for justice-involved populations.对影响涉司法人群阿片类药物过量预防因素的范围综述。
Subst Abuse Treat Prev Policy. 2021 Feb 22;16(1):19. doi: 10.1186/s13011-021-00346-1.
3
Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
在一组有定期注射吸毒史的被监禁男性中,监狱内带纳洛酮回家方案的可接受性。
Harm Reduct J. 2018 Sep 21;15(1):48. doi: 10.1186/s12954-018-0255-5.
4
Challenges in managing HIV in people who use drugs.管理吸毒者中艾滋病毒的挑战。
Curr Opin Infect Dis. 2015 Feb;28(1):10-6. doi: 10.1097/QCO.0000000000000125.